Back to results
US 6,727,244 B2Granted
Mammalian metabolites of a tachykinin receptor antagonist
AssigneeMerck & Co., Inc.
InventorsSu-er Wu Huskey, Shuet-Hing Lee Chiu
Life of this patent
Estimating the term…
Abstract
This invention is concerned with mammalian metabolites of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)-phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine which is a tachykinin receptor antagonist that is useful in the prevention and treatment of certain disorders, including emesis and psychiatric disorders such as depression and anxiety.
Claims6
A compound which is selected from the group consisting of:
- and pharmaceutically acceptable salts and individual diasteromers thereof in pure or partially purified form.
Dependencies are inferred from the claim text.